Clinical Trial Update: The Study Will Evaluate the Efficacy of AZD5423 in Patients With Mild Asthma Challenged With an Inhaled Allergen [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy of AZD5423 in mild asthma patients challenged with an inhaled allergen has completed, with results posted in April 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AZD5423

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2015-04-02